Results 151 to 160 of about 492,235 (272)

Radiological Change in Interstitial Lung Abnormalities and Interstitial Lung Disease in Patients With Rheumatoid Arthritis at 1 Year. [PDF]

Int J Rheum Dis
Mochizuki T, Katayanagi S, Sato M, Yano K, Okazaki K.   +4 more
europepmc   +1 more source

A Step‐by‐Step Guide to Successful Multiparametric Microbiota Flow Cytometry

Current Protocols, Volume 6, Issue 9, September 2026.
Abstract The role of the human microbiota in host health is an important area of research. Conventional characterization of the complex microbial communities colonizing the human body is primarily performed using culture‐based or high‐throughput sequencing approaches, which have improved general understanding yet lack cellular features relevant for ...
Toni Sempert, Lisa Budzinski, Robin Kempkens, Gi‐Ung Kang, René Maier, Hyun‐Dong Chang   +5 more
wiley   +1 more source

Ocular Clues in Musculoskeletal Disorders: A Narrative Review for Orthopaedic Specialists. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Alhomaidhi S, Alrabai HM, Alsabbagh L, Addar A.   +3 more
europepmc   +1 more source

Nailfold capillary phenotypes distinguish juvenile myositis subtypes and associate with disease activity

Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
Nailfold capillaroscopy is a non‐invasive imaging tool that can aid in the diagnosis and monitoring of juvenile myositis. Branched nailfold capillary morphology is more common in juvenile myositis patients, particularly those positive for TIF1γ+ autoantibodies. Juvenile myositis patients with more active disease demonstrate increased microhaemorrhages,
Nicholas McClellan, Li Chen, Sophia Matossian, Aurora Rynda, Kirsten Grant, Erin Janssen, J. Michelle Kahlenberg, Jessica L. Turnier   +7 more
wiley   +1 more source

Juvenile idiopathic arthritis presenting with orbital pseudotumor: A rare pediatric association. [PDF]

Radiol Case Rep
El Jebbouri K, Jabbari C, Haidar A, Belkouchi L, El Haddad S, Allali N, Chat L.   +6 more
europepmc   +1 more source

Synthetic Food Colorants and Gut Microbiota: A Systematic Review of Preclinical Studies

Food Frontiers, Volume 7, Issue 5, September 2026.
ABSTRACT Growing evidence suggests that industrial food processing, including the excess consumption of food additives, might have a negative impact on human health. Despite regulatory safety evaluations, their impact on gut microbiota remains poorly characterized.
Sebastiano Alfio Torrisi, Federica Martina Di Domenico, Gian Marco Leggio, Giuseppe Caruso, Evelyn Frias‐Toral, Nohora Milena Martínez López, Agnieszka Micek, Marialaura Bonaccio, Justyna Godos, Giuseppe Grosso   +9 more
wiley   +1 more source

Juvenile idiopathic arthritis (JIA) in Korea: epidemiology and biologic treatments. [PDF]

J Rheum Dis
Jung J, Lee SY.
europepmc   +1 more source

Association of Childhood Acute Leukemia With Autoimmune Diseases

International Journal of Cancer, Volume 159, Issue 5, Page 1188-1195, 1 September 2026.
A possible link exists between various pediatric autoimmune diseases (AIDs) and increased risk of childhood leukemia. Although immune dysregulation is a key feature of these conditions, the connection between them remains unclear. In this study, using cancer registry data in Finland, the authors examined associations between AIDs and childhood acute ...
Ida Pellikka, Julia Ventelä, Anssi Auvinen, Olli Lohi, Atte Nikkilä   +4 more
wiley   +1 more source

The Effect of Mobilization With Movement Techniques on Pain and Range of Elbow Extension in Juvenile Idiopathic Arthritis, a Case Report. [PDF]

Clin Case Rep
Bokaee F, Roghani T.
europepmc   +1 more source

Indicators of Suboptimal Treatment Among Patients With Crohn's Disease Treated With Ustekinumab or Risankizumab and Treatment Journey Among Ustekinumab Discontinuers in the United States

JCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background and Aims Patients with Crohn's disease (CD) may experience suboptimal response to advanced therapies (ATs), including interleukin (IL)‐12/23 inhibitor ustekinumab and IL‐23 inhibitor risankizumab. In an evolving treatment landscape, this study evaluated indicators of suboptimal treatment with these agents. Methods This retrospective
Freddy Caldera, Maryia Zhdanava, Sumesh Kachroo, Lilian Diaz, Aditi Shah, Fengyi Jiang, Caroline Kerner, Dominic Pilon, Jennifer Seminerio   +8 more
wiley   +1 more source